Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-11-07

Clinical Trial Update: Induction of Remission in Autoimmune Hepatitis With Azathioprine vs. MMF [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial evaluating induction of remission in autoimmune hepatitis with azathioprine versus mycophenolate mofetil; currently not recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Azathioprine (azathioprine)
  • MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)

Snippet

Sponsor: Institute of Liver and Biliary Sciences, India | Conditions: Autoimmune Hepatitis | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING